Rating History for 9/23/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals
(Oppenheimer - Matthew Hershenhorn) |
ACAD | Maintain | Perform (N/A) |
25.00 (N/A) |
|
Details | |||
| Acadia Realty Trust
(KeyBanc - Todd Thomas) |
AKR | Maintain | Overweight (N/A) |
25.00 (N/A) |
|
Details | |||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 196 more... | |||||||||


